One year of treatment with saroglitazar, Zydus Therapeutics’ experimental oral candidate, outperformed a placebo at normalizing markers of liver injury in people with primary biliary cholangitis (PBC), according to top-line data from a Phase 2b/3 clinical trial. The new findings mean that the Phase 2b/3 EPICS-III study (NCT05133336) — which included adults who did not […] The post New trial data show saroglitazar works to ease liver damage in PBC appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
I have mixed feelings as summer begins to pack up shop for the year. This season has a certain energy, like a house party with your best friends that you hope will never end. Still, I’ve found one silver lining for my health: The sun setting earlier means better sleep for me. Getting consistent, quality […] The post With liver disease, getting a good night’s sleep is crucial appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
While different types of progressive familial intrahepatic cholestasis (PFIC) vary in their genetic cause and clinical profile, new medications like Bylvay (odevixibat) and Livmarli (maralixibat) have shown promise across several PFIC types, including rare ones, in children. That’s according to a review study, titled “New hope in treating progressive familial intrahepatic cholestasis in children,” which […] The post New medications show promise for children with rare liver disease app...| Liver Disease News – The Web's Daily Resource for Liver Disease News
Columnist Jay Sandstrom didn't expect his son's routine surgery to involve complications. But with Alagille syndrome, anything is possible.| Liver Disease News
Babies who had standard Kasai surgery when they were more than 60 days old or had spleen malformations were more likely to have poor outcomes from biliary atresia, a study found. These factors were better than blood markers of liver damage measured before surgery at predicting long-term liver survival. “Age at surgery and BASM [biliary atresia […] The post Age at Kasai, spleen issues key to biliary atresia outcomes appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Health Canada has authorized a point-of-care test that may be used to quickly diagnose hepatitis C and monitor treatment response.| Liver Disease News
A blood marker of inflammation called lymphocyte-to-monocyte ratio (LMR) is an independent predictor of liver recompensation — when liver function improves with treatment despite permanent scarring — in people with primary biliary cholangitis (PBC). That’s according to a new study from researchers in China that showed that higher blood LMR levels — denoting a less active […] The post Blood marker can predict liver function improvement in PBC appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
My daughter has never asked much about my health, let alone how I live with metabolic dysfunction-associated steatohepatitis (MASH). I don’t expect her to care about my liver any more than my two cats do. As the mother of these three living beings (my daughter would be offended if you didn’t recognize our cats as […] The post MASH motivates me to help my family make healthy choices appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Mitochondrial problems may contribute to cholestasis-related liver damage and represent a potential therapeutic target, a study reports.| Liver Disease News
My son Finley is like most other kids his age: He benefits from routine and likes knowing what to expect. He’s not a fan of any deviation from what he wants his plans to be. I can admire his steadfastness, but at times his inflexibility can cause major difficulties. Throw in the fact that he […] The post New battles royales as new medicines are added to the mix appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Rezdiffra has become the first approved therapy for some people with severe fatty liver disease in the European Union.| Liver Disease News
Read about his other PH news from around the web.| Liver Disease News
The FDA has conditionally approved Wegovy (semaglutide) to treat certain people with a serious form of fatty liver disease.| Liver Disease News
Hepatitis B treatment needs a global overhaul to meet the WHO’s goal of eliminating the virus as a public health threat by 2030, per a study.| Liver Disease News
The Web's Daily Resource for Liver Disease News| Liver Disease News
Columnist Kathryn Hudson has been tempted to seek advice from "Dr. Google," but she knows it's a poor substitute for a medical professional.| Liver Disease News
Eating healthy foods is vital with liver disease, but inflation can make this challenging. Columnist Kathryn Hudson shares her budget tips.| Liver Disease News
Category archive page for Fatty liver disease.| Liver Disease News
The Phase 1b/2a study will continue recruiting adults with PBC with cognitive difficulties and fatigue at sites in the U.K. and Europe.| Liver Disease News
A newly developed algorithm showed a potential to identify people with MASLD and MASH based on data in their electronic health records.| Liver Disease News
Biliary atresia treatment, typically including the surgery Kasai portoenterostomy, aims to ensure bile flows properly into the intestines.| Liver Disease News
Color changes in the skin, urine, and stools are hallmark symptoms of biliary atresia, a rare liver disease seen in infants soon after birth.| Liver Disease News
Biliary atresia, a liver disease affecting infants, has blocked or absent bile ducts as its causes and jaundice and pale stools as symptoms.| Liver Disease News
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a...| Liver Disease News
Hepatitis treatment differs based on the type of hepatitis a person has, and include therapies to address the cause of liver inflammation.| Liver Disease News
Hepatitis C is a viral infection spread through contact with bodily fluids and causes a range of symptoms affecting the liver.| Liver Disease News
A genetic disease, Alagille syndrome can cause a wide range of symptoms, including liver problems, and affects about 1 in 30,000 newborns.| Liver Disease News
A range of treatment options, including medications and procedures, are available for managing Alagille syndrome symptoms.| Liver Disease News
Common symptoms of cholestasis, a condition affecting the flow of bile from the liver, include jaundice and itchy skin.| Liver Disease News
Cholestasis, or problems with liver bile flow, can have different causes and occur in pregnancy, with symptoms like jaundice and dark urine.| Liver Disease News
Category archive page for News.| Liver Disease News
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.| Liver Disease News
The American Liver Foundation's 2025 Liver Life Walk spotlights Domenic Frappolli of Dallas, who was born with biliary atresia.| Liver Disease News
Category archive page for Columns.| Liver Disease News